Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 4654958, 15 pages
https://doi.org/10.1155/2017/4654958
Research Article

Design, Development, and Optimization of Dexibuprofen Microemulsion Based Transdermal Reservoir Patches for Controlled Drug Delivery

1Department of Pharmaceutics, Faculty of Pharmacy, University of Karachi, Karachi, Pakistan
2H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan

Correspondence should be addressed to Muhammad Harris Shoaib; kp.ude.kou@biaohshm

Received 7 May 2017; Revised 25 June 2017; Accepted 4 July 2017; Published 27 September 2017

Academic Editor: Sanyog Jain

Copyright © 2017 Fatima Ramzan Ali et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. A. E. Benson, “Transdermal drug delivery: Penetration enhancement techniques,” Current Drug Delivery, vol. 2, no. 1, pp. 23–33, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. B. W. Barry, “Novel mechanisms and devices to enable successful transdermal drug delivery,” European Journal of Pharmaceutical Sciences, vol. 14, no. 2, pp. 101–114, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. M. J. Lawrence and G. D. Rees, “Microemulsion-based media as novel drug delivery systems,” Advanced Drug Delivery Reviews, vol. 45, no. 1, pp. 89–121, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Kreilgaard, “Influence of microemulsions on cutaneous drug delivery,” Advanced Drug Delivery Reviews, vol. 54, supplement 1, pp. S77–S98, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. M. R. Prausnitz, S. Mitragotri, and R. Langer, “Current status and future potential of transdermal drug delivery,” Nature Reviews Drug Discovery, vol. 3, no. 2, pp. 115–124, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Bonabello, M. Galmozzi, R. Canaparo et al., “Dexibuprofen (S (+)-isomer ibuprofen) reduces gastric damage and improves analgesic and antiinflammatory effects in rodents,” Anesthesia & Analgesia, vol. 97, pp. 402–408, 2003. View at Google Scholar
  7. S. T. Kaehler, W. Phleps, and E. Hesse, “Dexibuprofen: Pharmacology, therapeutic uses and safety,” Inflammopharmacology, vol. 11, no. 4-6, pp. 371–383, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Abdelbary and A. Makhlouf, “Adoption of polymeric micelles to enhance the oral bioavailability of dexibuprofen: Formulation, in-vitro evaluation and in-vivo pharmacokinetic study in healthy human volunteers,” Pharmaceutical Development and Technology, vol. 19, no. 6, pp. 717–727, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. S. L. Prabu, T. S. Prakash, S. Thiyagarajan, M. Amritha, R. Manibharathi, and N. Priyadharsini, “Design and evaluation of matrix diffusion controlled transdermal patches of dexibuprofen,” The Journal of Applied Research, vol. 12, pp. 38–46, 2012. View at Google Scholar
  10. M. A. Roni and R-u. Jalil, “Comparative study of ibuprofen solubility in synthetic and natural lipid vehicles,” Dhaka University Journal of Pharmaceutical Sciences, vol. 10, pp. 65-66, 2012. View at Google Scholar
  11. H. Chen, X. Chang, D. Du, J. Li, H. Xu, and X. Yang, “Microemulsion-based hydrogel formulation of ibuprofen for topical delivery,” International Journal of Pharmaceutics, vol. 315, no. 1-2, pp. 52–58, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Duangjit, L. M. Mehr, M. Kumpugdee-Vollrath, and T. Ngawhirunpat, “Role of simplex lattice statistical design in the formulation and optimization of microemulsions for transdermal delivery,” Biological and Pharmaceutical Bulletin, vol. 37, no. 12, pp. 1948–1957, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. H. HO, F. HUANG, T. D. SOKOLOSKI, and M. SHEU, “The Influence of Cosolvents on the In‐vitro Percutaneous Penetration of Diclofenac Sodium From a Gel System,” Journal of Pharmacy and Pharmacology, vol. 46, no. 8, pp. 636–642, 1994. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Jumaa, P. Kleinebudde, and B. W. Müller, “Physicochemical properties and hemolytic effect of different lipid emulsion formulations using a mixture of emulsifiers,” Pharmaceutica Acta Helvetiae, vol. 73, no. 6, pp. 293–301, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Subramanian, S. Ray, S. K. Ghosal, R. Bhadra, and S. P. Moulik, “Formulation design of self-microemulsifying drug delivery systems for improved oral bioavailability of celecoxib,” Biological and Pharmaceutical Bulletin, vol. 27, no. 12, pp. 1993–1999, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. W. Zhu, A. Yu, W. Wang, R. Dong, J. Wu, and G. Zhai, “Formulation design of microemulsion for dermal delivery of penciclovir,” International Journal of Pharmaceutics, vol. 360, no. 1-2, pp. 184–190, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Chen, X. Chang, T. Weng et al., “A study of microemulsion systems for transdermal delivery of triptolide,” Journal of Controlled Release, vol. 98, no. 3, pp. 427–436, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Hameed, S. A. Ali, A. A. Khan et al., “Solvent-free click chemistry for tetrazole synthesis from 1, 8-diazabicyclo [5.4. 0] undec-7-ene (DBU)-Based fluorinated ionic liquids, their micellization, and density functional theory studies,” RSC Advances, vol. 4, pp. 64128–64137, 2014. View at Google Scholar
  19. S.-R. Kim, J.-K. Kim, J.-S. Park, and C.-K. Kim, “Dry elixir formulations of dexibuprofen for controlled release and enhanced oral bioavailability,” International Journal of Pharmaceutics, vol. 404, no. 1-2, pp. 301–307, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. R. W. Baker, Controlled Release of Biologically Active Agents, John Wiley & Sons, 1987.
  21. K. D. Rainsford, Ibuprofen: pharmacology, Therapeutics and Side Effects, Springer Science & Business Media, 2013.
  22. USP34 N, “United States Pharmacopeial Convention,” 2011, Rockville, MD.
  23. P. Costa and J. M. Sousa Lobo, “Evaluation of mathematical models describing drug release from estradiol transdermal systems,” Drug Development and Industrial Pharmacy, vol. 29, no. 1, pp. 89–97, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Prodduturi, G. J. Smith, A. M. Wokovich, W. H. Doub, B. J. Westenberger, and L. Buhse, “Reservoir based fentanyl transdermal drug delivery systems: Effect of patch age on drug release and skin permeation,” Pharmaceutical Research, vol. 26, no. 6, pp. 1344–1352, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Panigrahi, S. Pattnaik, and S. K. Ghosal, “The effect of pH and organic ester penetration enhancers on skin permeation kinetics of terbutaline sulfate from pseudolatex-type transdermal delivery systems through mouse and human cadaver skins,” AAPS PharmSciTech, vol. 6, no. 2, article no. 25, pp. E167–E173, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. N. Kalia and R. H. Guy, “Modeling transdermal drug release,” Advanced Drug Delivery Reviews, vol. 48, no. 2-3, pp. 159–172, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Amrish and S. P. Kumar, “Transdermal delivery of ketorolac,” Yakugaku Zasshi, vol. 129, no. 3, pp. 373–379, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Chandra and P. Sharma, “Proniosome based drug delivery system of piroxicam,” African Journal of Pharmacy and Pharmacology, vol. 2, pp. 184–190, 2008. View at Google Scholar
  29. W. Pichayakorn, J. Suksaeree, P. Boonme, W. Taweepreda, T. Amnuaikit, and G. C. Ritthidej, “Deproteinised natural rubber used as a controlling layer membrane in reservoir-type nicotine transdermal patches,” Chemical Engineering Research and Design, vol. 91, no. 3, pp. 520–529, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Zhao, Y. Wang, Y. Zhai, Z. Wang, J. Liu, and G. Zhai, “Ropivacaine loaded microemulsion and microemulsion-based gel for transdermal delivery: Preparation, optimization, and evaluation,” International Journal of Pharmaceutics, vol. 477, no. 1, pp. 47–56, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. S. A. Safran and L. A. Turkevich, “Phase diagrams for microemulsions,” Physical Review Letters, vol. 50, no. 24, pp. 1930–1933, 1983. View at Publisher · View at Google Scholar · View at Scopus
  32. R. N. Healy, R. L. Reed, and D. Stenmark, “Multiphase microemulsion systems,” Society of Petroleum Engineers Journal, vol. 16, pp. 147–160, 1976. View at Google Scholar
  33. N. Üstündağ Okur, E. Ş. Çağlar, M. D. Arpa, and H. Y. Karasulu, “Preparation and evaluation of novel microemulsion-based hydrogels for dermal delivery of benzocaine,” Pharmaceutical Development and Technology, vol. 22, no. 4, pp. 500–510, 2017. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Peltola, P. Saarinen-Savolainen, J. Kiesvaara, T. M. Suhonen, and A. Urtti, “Microemulsions for topical delivery of estradiol,” International Journal of Pharmaceutics, vol. 254, no. 2, pp. 99–107, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Baroli, M. A. López-Quintela, M. B. Delgado-Charro, A. M. Fadda, and J. Blanco-Méndez, “Microemulsions for topical delivery of 8-methoxsalen,” Journal of Controlled Release, vol. 69, no. 1, pp. 209–218, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Moghimipour, A. Salimi, and S. Eftekhari, “Design and characterization of microemulsion systems for naproxen,” Advanced Pharmaceutical Bulletin, vol. 3, pp. 63–71, 2013. View at Google Scholar
  37. B. Kumar, S. K. Jain, S. K. Prajapati, A. Mahor, and A. Kumar, “Development and characterization of transdermal microemulsion gel for an antiviral drug,” International Journal of Pharmaceutical Sciences and Research, vol. 1, pp. 57–74, 2010. View at Google Scholar
  38. B. Biswal, N. Karna, J. Nayak, and V. Joshi, “Formulation and evaluation of microemulsion based topical hydrogel containing lornoxicam,” vol. 4, no. 12, pp. 077–084, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Kogan and N. Garti, “Microemulsions as transdermal drug delivery vehicles,” Advances in Colloid and Interface Science, vol. 123-126, pp. 369–385, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. S. T. Milner and S. A. Safran, “Dynamical fluctuations of droplet microemulsions and vesicles,” Physical Review A, vol. 36, no. 9, pp. 4371–4379, 1987. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Cavalli, O. Caputo, M. E. Carlotti, M. Trotta, C. Scarnecchia, and M. R. Gasco, “Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles,” International Journal of Pharmaceutics, vol. 148, no. 1, pp. 47–54, 1997. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Hadgraft and M. E. Lane, “Passive transdermal drug delivery systems: Recent considerations and advances,” American Journal of Drug Delivery, vol. 4, no. 3, pp. 153–160, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. P. Costa and J. M. Sousa Lobo, “Modeling and comparison of dissolution profiles,” European Journal of Pharmaceutical Sciences, vol. 13, no. 2, pp. 123–133, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. S. A. Wissing and R. H. Müller, “Solid lipid nanoparticles as carrier for sunscreens: In vitro release and in vivo skin penetration,” Journal of Controlled Release, vol. 81, no. 3, pp. 225–233, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. D. Thacharodi and K. P. Rao, “Development and in vitro evaluation of chitosan-based transdermal drug delivery systems for the controlled delivery of propranolol hydrochloride,” Biomaterials, vol. 16, no. 2, pp. 145–148, 1995. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Azarmi, W. Roa, and R. Löbenberg, “Current perspectives in dissolution testing of conventional and novel dosage forms,” International Journal of Pharmaceutics, vol. 328, no. 1, pp. 12–21, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Siewert, J. Dressman, C. K. Brown et al., “FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms,” AAPS PharmSciTech, vol. 4, pp. 43–52, 2003. View at Google Scholar
  48. D. Chaisson, “Dissolution Performance Testing Of Transdermal Systems,” 1995.
  49. B. Godin and E. Touitou, “Transdermal skin delivery: Predictions for humans from in vivo, ex vivo and animal models,” Advanced Drug Delivery Reviews, vol. 59, no. 11, pp. 1152–1161, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. Y. Morimoto, T. Hatanaka, K. Sugibayashi, and H. Omiya, “Prediction of Skin Permeability of Drugs: Comparison of Human and Hairless Rat Skin,” Journal of Pharmacy and Pharmacology, vol. 44, no. 8, pp. 634–639, 1992. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Morimoto, S. Nagata, S. Yamaguchi, and Y. Fujino, “Depth profiling of deuterium implanted in thin films by the elastic recoil detection technique of transmission geometry,” Nuclear Inst. and Methods in Physics Research, B, vol. 48, no. 1-4, pp. 478–481, 1990. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Akhlaq, M. S. Arshad, A. M. Mudassir et al., “Formulation and evaluation of anti-rheumatic dexibuprofen transdermal patches: a quality-by-design approach,” Journal of Drug Targeting, vol. 24, no. 7, pp. 603–612, 2016. View at Publisher · View at Google Scholar · View at Scopus
  53. M.-K. Kim, H. Zhao, C.-H. Lee, and D.-D. Kim, “Formulation of a reservoir-type testosterone transdermal delivery system,” International Journal of Pharmaceutics, vol. 219, no. 1-2, pp. 51–59, 2001. View at Publisher · View at Google Scholar · View at Scopus
  54. H. Zhao, D.-W. Park, S.-K. Kim, C.-H. Lee, and D.-D. Kim, “The effects of pressure-sensitive adhesives and solubilizers on the skin permeation of testosterone from a matrix-type transdermal delivery system,” Drug Development and Industrial Pharmacy, vol. 28, no. 9, pp. 1125–1131, 2002. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Murphy and A. J. Carmichael, “Transdermal drug delivery systems and skin sensitivity reactions: Incidence and management,” American Journal of Clinical Dermatology, vol. 1, no. 6, pp. 361–368, 2000. View at Publisher · View at Google Scholar · View at Scopus
  56. A. J. Carmichael, “Skin Sensitivity and Transdermal Drug Delivery: A Review of the Problem,” Drug Safety, vol. 10, no. 2, pp. 151–159, 1994. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Venkatraman and R. Gale, “Skin adhesives and skin adhesion. 1. Transdermal drug delivery systems,” Biomaterials, vol. 19, no. 13, pp. 1119–1136, 1998. View at Publisher · View at Google Scholar · View at Scopus
  58. C. A. Winter, E. A. Risley, and G. W. Nuss, “Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs,” Proceedings of the Society for Experimental Biology and Medicine, vol. 3, pp. 544–547, 1962. View at Publisher · View at Google Scholar · View at Scopus
  59. C. J. Morris, “Carrageenan-induced paw edema in the rat and mouse,” Inflammation Protocols, pp. 115–121, 2003. View at Google Scholar
  60. S. G. I. Jin, A. M. E. Yousaf, M. W. O. Son et al., “Mechanical properties, skin permeation and in vivo evaluations of dexibuprofen-loaded emulsion gel for topical delivery,” Archives of pharmacal research, vol. 38, no. 2, pp. 216–222, 2015. View at Publisher · View at Google Scholar · View at Scopus
  61. A. G. Benecke, D. J. Kinne, and Wnuk. A. J., “Storage-stable transdermal patch,” Google Patents, 1991. View at Google Scholar